文献速递妇科生殖医学

子宫内膜异位症的临床管理

Clinical Management of Endometriosis.
PubMed 文献 · Obstet Gynecol · 2018-01-01

子宫内膜异位症是育龄期女性常见且具有挑战性的疾病,个体和社会成本高。手术仍是确诊的金标准,但需权衡手术并发症和卵巢储备下降风险,尤其是子宫内膜异位囊肿。药物治疗为抑制性而非治愈性,推荐长期、经济且副作用小的方案。

要点

  • 手术是确诊金标准,但需权衡手术并发症和卵巢储备下降风险。
  • 药物治疗为抑制性而非治愈性,推荐长期、经济且副作用小的方案。
  • 停药后复发常见且迅速;内异症相关不孕需评估手术指征。

核心结论

  • 子宫内膜异位症病变与在位内膜存在分子差异,给新药研发带来困难。
  • 手术是确诊金标准,但须权衡手术并发症和卵巢储备下降风险,尤其是子宫内膜异位囊肿。
  • 药物治疗为抑制性而非治愈性,推荐长期、经济且副作用小的方案;停药后复发常见且迅速。

研究设计与样本

  • 原文为综述,未报告系统检索范围。

主要发现

  • 子宫内膜异位症病变与在位内膜存在许多分子差异。
  • 手术是确诊金标准,但须权衡手术并发症和卵巢储备下降风险,尤其是子宫内膜异位囊肿。
  • 药物治疗为抑制性而非治愈性,停药后复发常见且迅速。
  • 慢性疼痛患者中,中枢敏化和肌筋膜疼痛是多学科管理的重要组成部分。
  • 子宫内膜异位症与上皮性卵巢癌风险增加相关,但风险低,目前不推荐预防性筛查。

临床怎么用

  • 术后绝经且有症状的女性,不应因担心恶性肿瘤或子宫内膜异位症复发而延迟激素治疗。
  • 子宫内膜异位症相关不孕患者,需讨论合适的管理,包括手术是否及何时有指征。
  • 慢性疼痛患者应采用多学科管理,涵盖中枢敏化和肌筋膜疼痛。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endometriosis is a common and challenging condition of reproductive-aged women that carries a high individual and societal cost. The many molecular dissimilarities between endometriosis lesions and eutopic endometrium create difficulties in the development of new drug therapies and treatments. Surgery remains the gold standard for definitive diagnosis, but it must be weighed against the risks of surgical morbidity and potential decreases in ovarian reserve, especially in the case of endometriomas. Safe and effective surgical techniques are discussed within this article for various presentations of endometriosis. Medical therapy is suppressive rather than curative, and regimens that are long-term and affordable with minimal side effects are recommended. Recurrences are common and often rapid when medical therapy is discontinued. Endometriosis in the setting of infertility is reviewed and appropriate management is discussed, including when and whether surgery is warranted in this at-risk population. In patients with chronic pain, central sensitization and myofascial pain are integral components of a multidisciplinary approach. Endometriosis is associated with an increased risk of epithelial ovarian cancer; however, the risk is low and currently no preventive screening is recommended. Hormone therapy for symptomatic women with postsurgical menopause should not be delayed as a result of concerns for malignancy or recurrence of endometriosis.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Falcone T, Flyckt R. Clinical Management of Endometriosis. Obstet Gynecol. 2018. PMID: 29420391. doi:10.1097/AOG.0000000000002469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。